MOTS-c FAQ: common questions answered
A peptide the body makes; injection benefits and safety remain unproven.
Also called: MOTS-C, Mitochondrial open reading frame of the 12S rRNA-c.
Mitochondrial-derived peptides · 16-amino-acid mitochondrial signaling peptide.
- Is MOTS-c FDA-approved? No. MOTS-c acetate: limited to subcutaneous, intramuscular forms. The October 30, 2026 Federal Register describes a nonbinding draft interim HHS 503A enforcement policy, with public comment invited. It is conditional on eligible state-licensed pharmacies, federal facilities or licensed physicians, a patient-specific prescription, a single active ingredient, specified identity and route, qualified manufacturing, lot testing, reporting and labeling conditions. It is not FDA drug approval, a final 503A listing or general authorization to supply research products.
- How do people take it? Under the skin, every 5 days. A 20-day course, repeated 6 months after the first course ends. 20 days. Source: reported by users, not an established dose.
- What's the difference between MOTS-c and SS-31 (elamipretide)? MOTS-c: a peptide the body makes; injection benefits and safety remain unproven. SS-31 (elamipretide): a peptide approved for Barth syndrome muscle strength; benefit needs confirmation and broader energy benefits remain unproven. Why people pair them: users describe an SS-31 course before MOTS-c for hoped-for mitochondrial support.
- Can I take it with SS-31 / elamipretide? Users describe an SS-31 course before MOTS-c for hoped-for mitochondrial support. No human trial has tested this combination; safety and added benefit are unknown. Source: reported by users. Ask a doctor before combining anything.
- Is it banned in sport? Yes. It is banned in and out of competition (WADA 2026). Named as an AMPK activator among metabolic modulators.
- How long does a mixed vial last? No validated home-mixed shelf life. Forum claims of only hours or weeks are not reliable stability data.
Related to MOTS-c
- Humanin: A peptide the body makes; injection benefits and safety remain unproven.
- Retatrutide: An experimental weekly injection with phase 3 weight-loss results.
- Ipamorelin: An experimental peptide that triggers growth hormone release.
- NAD+ and precursors: NAD+ helps cells use energy; wellness injection benefits remain unproven.
- Tesamorelin: A peptide approved for deep abdominal fat in adults with HIV lipodystrophy.
- SS-31 (elamipretide): A peptide approved for Barth syndrome muscle strength; benefit needs confirmation and broader energy benefits remain unproven.
Sources
- 503B Bulk Drug Substances List, FDA · FDA · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2026
- Cellulitis, NHS · NHS · 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA · FDA · 2026
- FDA Briefing Document: MOTS-c-Related Bulk Drug Substances (MOTS-c (free base) and MOTS-c acetate), FDA · 2026
- Federal Register: nonbinding draft HHS interim policy, October 30 2026, 2026
- Find product information about medicines, Medicines and Healthcare products Regulatory Agency · MHRA · 2026
- HHS 503A peptide interim enforcement policy and conditions, October 30 2026, 2026
- July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee - 07/23/2026, FDA · FDA · 2026
- Medicines, European Medicines Agency · European Medicines Agency · 2026
- Peptide products, Therapeutic Goods Administration · TGA · 2026
- Risks of buying peptide products online, Therapeutic Goods Administration · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you, Health Canada · Health Canada · 2026
- Anaphylaxis, NHS · NHS · 2023
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.